Patents by Inventor Robert Pohlmeier

Robert Pohlmeier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10646635
    Abstract: The present disclosure concerns a method for preparing an extracorporeal blood circuit for its use in a blood treatment of a patient, which treatment is carried out using a blood treatment apparatus and using a blood treatment device, which comprises a blood chamber and a dialysate chamber partitioned off therefrom by a membrane, The method comprising: filling the extracorporeal blood circuit using a priming solution, wherein the priming solution comprises citrate, or filling of the extracorporeal blood circuit using a priming solution and using a citrate solution. The invention further comprises devices suitable for carrying out the method.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: May 12, 2020
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Robert Pohlmeier, Wofgang Wehmeyer
  • Patent number: 10507275
    Abstract: A tube set for a blood handling apparatus, in particular an extracorporeal blood handling apparatus with an extracorporeal blood circuit or an apparatus for peritoneal dialysis, and a blood handling apparatus that has such a tube set are described. The tube set includes a device for collecting particles provided in a tube line portion of the tube set downstream of the tube portion placed in the occluding hose pump. The device for collecting particles prevents retention of solid substances that are possibly contained in the dialysis fluid, substituate or peritoneal solution. The tube set also has a device for limiting the pressure in the tube line portion between the occluding hose pump and the device for collecting particles. The device for limiting the positive pressure prevents an excessive positive pressure from building up in the tube line when fluid flow through the device for collecting particles is reduced or interrupted.
    Type: Grant
    Filed: August 13, 2010
    Date of Patent: December 17, 2019
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Michael Herrenbauer, Robert Pohlmeier, Andreas Laubrock, Angelika Bachmann
  • Patent number: 10172884
    Abstract: This document relates to bi-carbonate-buffered dialysis solutions with physiological phosphate content and increased stability. The solutions include an organic ester of phosphoric acid, calcium ions and/or magnesium ions, and optionally additional electrolytes, buffers and glucose in physiologically effective concentrations.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: January 8, 2019
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Jochen Huppert, Pascal Mathis, Robert Berlich, Robert Pohlmeier
  • Publication number: 20170304522
    Abstract: The present disclosure concerns a method for preparing an extracorporeal blood circuit for its use in a blood treatment of a patient, which treatment is carried out using a blood treatment apparatus and using a blood treatment device, which comprises a blood chamber and a dialysate chamber partitioned off therefrom by a membrane, The method comprising: filling the extracorporeal blood circuit using a priming solution, wherein the priming solution comprises citrate, or filling of the extracorporeal blood circuit using a priming solution and using a citrate solution. The invention further comprises devices suitable for carrying out the method.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 26, 2017
    Applicant: Fresenius Medical Care Deutschland GmbH
    Inventors: Robert Pohlmeier, Wofgang Wehmeyer
  • Publication number: 20170182094
    Abstract: This document relates to bi-carbonate-buffered dialysis solutions with physiological phosphate content and increased stability. The solutions include an organic ester of phosphoric acid, calcium ions and/or magnesium ions, and optionally additional electrolytes, buffers and glucose in physiologically effective concentrations.
    Type: Application
    Filed: March 15, 2017
    Publication date: June 29, 2017
    Inventors: Jochen Huppert, Pascal Mathis, Robert Berlich, Robert Pohlmeier
  • Patent number: 9629858
    Abstract: This document relates to bi-carbonate-buffered dialysis solutions with physiological phosphate content and increased stability. The solutions include an organic ester of phosphoric acid, calcium ions and/or magnesium ions, and optionally additional electrolytes, buffers and glucose in physiologically effective concentrations.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: April 25, 2017
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Jochen Huppert, Pascal Mathis, Robert Berlich, Robert Pohlmeier
  • Patent number: 9592329
    Abstract: The present invention relates to a system for the carrying out of a blood treatment, in particular a dialysis treatment, wherein the system has at least one blood treatment device, in particular a dialyzer, and at least one tank from which treatment fluid, in particular dialysis fluid, is removed during the carrying out of the blood treatment and/or into which consumed treatment fluid, in particular consumed dialysis fluid, is filled during the carrying out of the blood treatment, wherein the tank is an element of at least one mobile apparatus which can be connected to the blood treatment device such that at least one fluid connection can be established between the tank and the blood treatment device.
    Type: Grant
    Filed: March 14, 2011
    Date of Patent: March 14, 2017
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Robert Pohlmeier, Michael Herrenbauer, Patricia Goempel-Klein, Alfred Krause, Wolfgang Wehmeyer
  • Publication number: 20160367573
    Abstract: This document relates to bi-carbonate-buffered dialysis solutions with physiological phosphate content and increased stability. The solutions include an organic ester of phosphoric acid, calcium ions and/or magnesium ions, and optionally additional electrolytes, buffers and glucose in physiologically effective concentrations.
    Type: Application
    Filed: June 15, 2016
    Publication date: December 22, 2016
    Inventors: Jochen Huppert, Pascal Mathis, Robert Berlich, Robert Pohlmeier
  • Patent number: 9345825
    Abstract: The invention relates to a dialysis device (1) having a dialysate circuit comprising a first dialyzer (3) and a second dialyzer (5) wherein the first dialyzer (3) is connectable to a blood circulation of a patient via a blood feed line (11) and a recirculation (13), an effluent for a retentate flow (Qeffluent) from the dialysate circuit to the second dialyzer (5) is provided and a permetate stream (Qout) of the second dialyzer (5) in the dialysate circuit is passed to the first dialyzer (3), the second dialyzer (5) comprising a filter membrane having a cut-off value of at least 500 Da and the first dialyzer (3) comprising a filter membrane having a cut-off value exceeding that of the second dialyzer (5).
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: May 24, 2016
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Michael Herrenbauer, Robert Pohlmeier
  • Patent number: 8900172
    Abstract: The present invention relates to a method for controlling or regulating an apparatus for extracorporeally treating blood in an extracorporeal blood circuit while adding citrate and calcium for the purpose of anticoagulation. The apparatus comprises a dispensing device for dispensing a calcium solution into the extracorporeal blood circuit. The method encompasses outputting a signal to the dispensing device for altering a setting of the dispensing device, in which the setting corresponds to or effects an addition of calcium, a calcium dosage, concentration, amount or rate. The method further encompasses defining or altering the signal with regard to a calcium content or a calcium concentration of a substituate solution used in extracorporeally treating the blood, and detecting the range of values of permissible or allowed settings for the calcium introduced or to be introduced into the extracorporeal blood circuit by the dispensing device, particularly its amount, concentration or dosage.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: December 2, 2014
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventor: Robert Pohlmeier
  • Publication number: 20130001165
    Abstract: The present invention relates to a system for the carrying out of a blood treatment, in particular a dialysis treatment, wherein the system has at least one blood treatment device, in particular a dialyzer, and at least one tank from which treatment fluid, in particular dialysis fluid, is removed during the carrying out of the blood treatment and/or into which consumed treatment fluid, in particular consumed dialysis fluid, is filled during the carrying out of the blood treatment, wherein the tank is an element of at least one mobile apparatus which can be connected to the blood treatment device such that at least one fluid connection can be established between the tank and the blood treatment device.
    Type: Application
    Filed: March 14, 2011
    Publication date: January 3, 2013
    Inventors: Robert Pohlmeier, Michael Herrenbauer, Patricia Goempel-Klein, Alfred Krause, Wolfgang Wehmeyer
  • Publication number: 20120203159
    Abstract: The present invention relates to a method for controlling or regulating an apparatus for extracorporeally treating blood in an extracorporeal blood circuit while adding citrate and calcium for the purpose of anticoagulation. The apparatus comprises a dispensing device for dispensing a calcium solution into the extracorporeal blood circuit. The method encompasses outputting a signal to the dispensing device for altering a setting of the dispensing device, in which the setting corresponds to or effects an addition of calcium, a calcium dosage, concentration, amount or rate. The method further encompasses defining or altering the signal with regard to a calcium content or a calcium concentration of a substituate solution used in extracorporeally treating the blood, and detecting the range of values of permissible or allowed settings for the calcium introduced or to be introduced into the extracorporeal blood circuit by the dispensing device, particularly its amount, concentration or dosage.
    Type: Application
    Filed: February 3, 2012
    Publication date: August 9, 2012
    Applicant: Fresenius Medical Care Deutschaland GmbH
    Inventor: Robert Pohlmeier
  • Publication number: 20120165718
    Abstract: A tube set for a blood handling apparatus, in particular an extracorporeal blood handling apparatus with an extracorporeal blood circuit or an apparatus for peritoneal dialysis, and a blood handling apparatus that has such a tube set are described. The tube set includes a device for collecting particles provided in a tube line portion of the tube set downstream of the tube portion placed in the occluding hose pump. The device for collecting particles prevents retention of solid substances that are possibly contained in the dialysis fluid, substituate or peritoneal solution. The tube set also has a device for limiting the pressure in the tube line portion between the occluding hose pump and the device for collecting particles. The device for limiting the positive pressure prevents an excessive positive pressure from building up in the tube line when fluid flow through the device for collecting particles is reduced or interrupted.
    Type: Application
    Filed: August 13, 2010
    Publication date: June 28, 2012
    Inventors: Michael Herrenbauer, Robert Pohlmeier, Andreas Laubrock, Angelika Bachmann
  • Publication number: 20120097587
    Abstract: The invention relates to a dialysis device (1) having a dialysate circuit comprising a first dialyzer (3) and a second dialyzer (5) wherein the first dialyzer (3) is connectable to a blood circulation of a patient via a blood feed line (11) and a recirculation (13), an effluent for a retentate flow (Qeffluent) from the dialysate circuit to the second dialyzer (5) is provided and a permetate stream (Qout) of the second dialyzer (5) in the dialysate circuit is passed to the first dialyzer (3), the second dialyzer (5) comprising a filter membrane having a cut-off value of at least 500 Da and the first dialyzer (3) comprising a filter membrane having a cut-off value exceeding that of the second dialyzer (5).
    Type: Application
    Filed: June 9, 2010
    Publication date: April 26, 2012
    Inventors: Michael Herrenbauer, Robert Pohlmeier